European Archives - Page 1073 of 1201 - European Medical Journal

EMJ

Treatment of pancreatic cancer: Overview of the continued progress

Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…

Daratumumab (DARZALEX®) Combination Therapy Significantly Extended Progression-Free Survival in Previously Treated Patients with Multiple Myeloma

Beerse, Belgium, 5 June 2016 – Data from the Phase 3 MMY3004 (CASTOR) clinical trial show the immunotherapy daratumumab (DARZALEX®) in combination with a…

Helsinn Group Hosts a Satellite Symposium on Shared Decision Making in Supportive Care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th

Lugano, Switzerland, June 13, 2016 – Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announces that it is…

The DA-EPOCH-R clinical trial in Burkitt’s lymphoma

Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter prospective…

EMJ

Prehistoric Protein Could Hold the Key to Improving Treatments for Miscarriage

PIONEERING research in stem cell biology has discovered that a protein evolved from a viral infection in primates 25 million years ago may enhance…

EMJ

Seeing Double: Genes Increasing the Likelihood of Dizygotic Twins Discovered

A BREAKTHROUGH in the genetics of twinning has been made with the recent identification of genes that increase the prospect of dizygotic (DZ) twins, a…

New Janssen Phase 3 Data in Patients with Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms of Disease

London, United Kingdom, 8 June, 2016 – Janssen Research & Development, LLC (Janssen) announced today results from a pivotal Phase 3 study evaluating…

New Data Demonstrates Sandoz’ Etanercept and Rituximab Biosimilar Candidates Bioequivalent to Originator Products

Holzkirchen, June 9 2016 – Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from two key studies…

EMJ

T Cell Protein Provides New Leads in Understanding Immune Response

AN INNOVATIVE new study has uncovered a protein that is fundamental to controlling immune responses, which could provide much needed clarification of…

EMJ

New Insight into the Components of Pollen Proves Positive for Hay Fever Sufferers

NON-ALLERGENIC components of pollen do impact the body’s immune system, a recent study has uniquely revealed. The discovery could transform the future…